Combination chemotherapy for malignant mixed germ cell tumours of the ovary: a prospective study. 1988

P Singh, and E L Yordan, and J R Graham, and G D Wilbanks, and R E Slayton, and A W Miller

UI MeSH Term Description Entries
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004407 Dysgerminoma A malignant ovarian neoplasm, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. It is the counterpart of the classical seminoma of the testis, to which it is both grossly and histologically identical. Dysgerminomas comprise 16% of all germ cell tumors but are rare before the age of 10, although nearly 50% occur before the age of 20. They are generally considered of low-grade malignancy but may spread if the tumor extends through its capsule and involves lymph nodes or blood vessels. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1646) Disgerminoma,Disgerminomas,Dysgerminomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

P Singh, and E L Yordan, and J R Graham, and G D Wilbanks, and R E Slayton, and A W Miller
March 1988, Cancer,
P Singh, and E L Yordan, and J R Graham, and G D Wilbanks, and R E Slayton, and A W Miller
December 1981, Gynecologic oncology,
P Singh, and E L Yordan, and J R Graham, and G D Wilbanks, and R E Slayton, and A W Miller
January 2011, Medicinski pregled,
P Singh, and E L Yordan, and J R Graham, and G D Wilbanks, and R E Slayton, and A W Miller
September 1992, Indian journal of cancer,
P Singh, and E L Yordan, and J R Graham, and G D Wilbanks, and R E Slayton, and A W Miller
October 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
P Singh, and E L Yordan, and J R Graham, and G D Wilbanks, and R E Slayton, and A W Miller
October 1978, Nederlands tijdschrift voor geneeskunde,
P Singh, and E L Yordan, and J R Graham, and G D Wilbanks, and R E Slayton, and A W Miller
June 1985, Nihon Sanka Fujinka Gakkai zasshi,
P Singh, and E L Yordan, and J R Graham, and G D Wilbanks, and R E Slayton, and A W Miller
October 1985, British journal of urology,
P Singh, and E L Yordan, and J R Graham, and G D Wilbanks, and R E Slayton, and A W Miller
August 1989, Zeitschrift fur Kinderchirurgie : organ der Deutschen, der Schweizerischen und der Osterreichischen Gesellschaft fur Kinderchirurgie = Surgery in infancy and childhood,
P Singh, and E L Yordan, and J R Graham, and G D Wilbanks, and R E Slayton, and A W Miller
April 1978, Indian journal of pathology & microbiology,
Copied contents to your clipboard!